# University of Zurich

> University of Zurich is a VC fund backing Health Care and Life Science. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Zürich, Switzerland
- Total investments: 1
- Last investment: May 2021
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/uzh
- X (Twitter): http://twitter.com/uzh_news_en
- Website: https://www.uzh.ch/en.html
- Facebook: http://www.facebook.com/uzh.ch

University of Zurich is a higher education institute that offers a wide variety of Master’s, Bachelor’s, and Ph.D. programs. The company also specializes in the fields of clinical medicine, immunology, neuroscience, and structural biology as well as in economics. It also brings benefits to both the private and the public sectors. It makes findingsfrom cutting-edge research available to the public in accessible and engaging lecture series and panel discussions.In addition, the University of Zurich providing a dynamic education based on critical thinking and interdisciplinary exposure. The university is committed to being an internationally significant research university, with graduate, undergraduate, and professional programs of excellent quality.University of Zurich was founded on April 29, 1833, and is headquartered in Zurich, Switzerland.

## Contacts

5 contacts available for University of Zurich. Shizune tracks 14 team members at University of Zurich. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/university-of-zurich?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Life Science | 1 | 100% |
| Biotechnology | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Michio Painter | Head of the Therapy Development Accelerator | 3 | https://shizune.co/investors/profile/michio-painter-15a2 |
| Aron Kirschner | Research Associate | 0 | https://shizune.co/investors/profile/aron-kirschner |
| Beth Singler | Assistant Professor in Digital Religion | 0 | https://shizune.co/investors/profile/beth-singler |
| Burkhard Becher | Co-Chair | 0 | https://shizune.co/investors/profile/burkhard-becher |
| Claudio Tessone | Professor of Blockchain & Distributed Ledger Technologies | 0 | https://shizune.co/investors/profile/claudio-tessone |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MUVON Therapeutics | Muvon Therapeutics platform helps women with urinary incontinence and treats diseases based on skeletal muscle degradation, supporting them in their commitment to living a healthy life. The company's mode of contact is by mail, phone, and physical address. |  | Series A | May 31, 2021 |  |

1 of 1 investments shown.

## Co-investors
- [Horizon 2020](https://shizune.co/investors/profile/horizon-2020) — VC Fund, 1 deal together
- [Lichtsteiner Foundation](https://shizune.co/investors/profile/lichtsteiner-foundation) — VC Fund, 1 deal together
- [Wyss Zurich](https://shizune.co/investors/profile/wyss-zurich) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [SICTIC](https://shizune.co/investors/profile/sictic) — VC Fund
- [Zürcher Kantonal Bank](https://shizune.co/investors/profile/z%C3%BCrcher-kantonalbank) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund

## Featured in investor lists
- [Life Science Investors in Switzerland](https://shizune.co/investors/life-science-investors-switzerland)

## FAQ

### What does University of Zurich invest in?

University of Zurich invests primarily in Health Care, Life Science and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact University of Zurich?

Public channels for University of Zurich include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at University of Zurich?

The team at University of Zurich includes Michio Painter (Head of the Therapy Development Accelerator), Aron Kirschner (Research Associate) and Beth Singler (Assistant Professor in Digital Religion), among 14 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co